Stocks-1801.HK-Innovent Biologics Inc

1801.HK Innovent Biologics Inc

27.71 -0.25 (-0.89%)
Invest
Invest

Overview

Prev Close27.71
Day's Range 26.46 - 28.71
52 Week Range 18.02 - 67.99
Average Volume (3m)12.3M
1-Year Return-55.01%
Beta0.1958
Market Cap42.52B
P/E Ratio14.17
Revenue5.52B
EPS-2.4118
Dividend (Yield) (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.722/06/202202/09/202216/11/202222.5025.0027.5030.0032.5035.0037.5040.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO De Chao Yu, PhD
Employees 5,568

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Innovent Biologics Inc's revenues increased by 18.90% and amounted to 5.14B. Net income increased by 340.95% to 2.70B. Net assets decreased by NaN to N/A and EPS decreased from -0.83 to N/A.
1801.HK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Gross Margin
82.27%
Net Profit Margin
-12,839.40%
Operating Margin
-61.14%
Return On Investment
-43.95%
2018
2019
2020
2021
Total Revenue
11.23M
1.19B
4.32B
5.14B
Gross Profit
N/A
1B
3.88B
N/A
Operating Income
-1.86B
-2.06B
-194.54M
N/A
Net Income
-6.96B
-1.95B
-1.12B
2.7B